BRIEF published on 11/17/2025 at 15:19, 3 months 4 days ago Amundi Physical Metals plc: ETC Securities Offering Finalized ETC Securities Final Terms Gold Investment Amundi Metals Financial Listing
BRIEF published on 11/17/2025 at 15:19, 3 months 4 days ago Amundi Physical Metals plc : Finalisation de l’offre de titres ETC ETC Securities Investissement En Or Cotation Financière Conditions Finales Amundi Métaux
BRIEF published on 11/17/2025 at 15:13, 3 months 4 days ago Amundi Physical Metals plc: Final Terms for UK Market Regulation Gold Listing Amundi ETC Securities
BRIEF published on 11/17/2025 at 15:13, 3 months 4 days ago Amundi Physical Metals plc : Conditions finales pour le marché britannique Or Amundi ETC Securities Inscription Règlement
BRIEF published on 11/17/2025 at 14:37, 3 months 4 days ago Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG: Updated Buy Recommendation Buy Recommendation Portfolio Expansion Convertible Bond Price Target DEWB
BRIEF published on 11/17/2025 at 14:37, 3 months 4 days ago Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG : recommandation d'achat mise à jour Recommandation D'achat Objectif De Prix Expansion Du Portefeuille Obligation Convertible DEWB
BRIEF published on 11/17/2025 at 14:35, 3 months 4 days ago Kidoz Inc. to Reveal Q3 2025 Financial Results Financial Results Annual General Meeting Kidoz Inc. Q3 2025 AdTech Platform
BRIEF published on 11/17/2025 at 14:35, 3 months 4 days ago Kidoz Inc. publiera ses résultats financiers du troisième trimestre 2025 Résultats Financiers Kidoz Inc. Assemblée Générale Annuelle 3e Trimestre 2025 Plateforme AdTech
BRIEF published on 11/17/2025 at 14:35, 3 months 4 days ago NanoViricides Fortifies Fiscal Position with Recent Funding NV-387 Financial Position Funding Clinical Trials Antiviral Drug
BRIEF published on 11/17/2025 at 14:35, 3 months 4 days ago NanoViricides renforce sa situation financière grâce à un financement récent NV-387 Financement Essais Cliniques Situation Financière Médicament Antiviral
Published on 02/21/2026 at 00:45, 20 hours 12 minutes ago Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 20 hours 27 minutes ago Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:15, 21 hours 42 minutes ago DigiPower X Announces Closing of Settlement
Published on 02/20/2026 at 23:00, 21 hours 57 minutes ago Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 22 hours 40 minutes ago Organto Foods Completes Warrant Exercise Incentive Program
Published on 02/21/2026 at 12:00, 8 hours 57 minutes ago Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Published on 02/21/2026 at 12:00, 8 hours 57 minutes ago Abivax présente, au Congrès de l’ECCO 2026, les premières preuves d’une activité antifibrotique d'obefazimod, ainsi que de nouvelles analyses de son efficacité et de sécurité dans les MICI
Published on 02/20/2026 at 18:36, 1 day 2 hours ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 1 day 2 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
